300239.SZ Stock Analysis
30
Neutral
Based on Eyestock quantitative analysis, 300239.SZ`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly undervalued
Baotou Dongbao Bio-Tech Co., Ltd. engages in the research and development, design, production, and sales of gelatin, collagen, and calcium hydrogen phosphate. The company is headquartered in Baotou, Neimenggu and currently employs 1,354 full-time employees. The company went IPO on 2011-07-06. The firm primarily provides gelatin, which is used in the manufacture of empty capsules and food additives; calcium hydrophosphate, which is used in feed additives, as well as collagen series products, which are used in foods, cosmetics, health care products. The firm distributes its products in both domestic and overseas markets, with domestic markets as its major markets.